We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+13.2%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.25B
AUM Growth
+$171M
(+16%)
Cap. Flow
+$78.7M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
54.58%
Holding
41
New
6
Increased
4
Reduced
14
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Well
AMWL
|
+$122M |
| 2 |
HCA Healthcare
HCA
|
+$44.3M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$40.8M |
| 4 |
Merck
MRK
|
+$38.3M |
| 5 |
Ross Stores
ROST
|
+$30.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$44.9M |
| 2 |
UnitedHealth
UNH
|
+$43M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$35M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$20.1M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.22% |
| 2 | Consumer Discretionary | 15.6% |
| 3 | Technology | 14.04% |
| 4 | Communication Services | 5.26% |
| 5 | Consumer Staples | 3.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Labcorp
LH
$25.5B
| $16.1M | 1.29% |
99,421
-283,036
| -74% | -$44.9M |
|
27
Inspire Medical Systems
INSP
$1.45B
| $13.6M | 1.09% |
105,411
-61,225
| -37% | -$6.75M |
|
28
Teva Pharmaceuticals
TEVA
$40.9B
| $13.5M | 1.08% |
1,500,000
| – | – |
|
29
DexCom
DXCM
$32.1B
| $12.9M | 1.03% |
125,108
-26,532
| -17% | -$2.77M |
|
30
Liberty Broadband Class A
LBRDA
$4.9B
| $12.5M | 1% |
87,833
| – | – |
|
|
BMY.RT
31
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $9.96M | 0.8% |
4,427,269
+2,601,266
| +142% | +$7.43M |
|
|
DRNA
32
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $9.05M | 0.72% |
503,012
-970,556
| -66% | -$20.1M |
|
33
Frontdoor
FTDR
$5.1B
| $8.76M | 0.7% |
225,000
| – | – |
|
34
Quanterix
QTRX
$164M
| $7.02M | 0.56% |
208,185
-37,977
| -15% | -$1.22M |
|
35
TG Therapeutics
TGTX
$8.01B
| $6.88M | 0.55% |
256,897
-432,924
| -63% | -$9.96M |
|
36
Alector
ALEC
$170M
| $2.41M | 0.19% |
+229,117
| New | +$3.71M |
|
37
BellRing Brands
BRBR
$1.47B
| – | – |
-100,000
| Closed | -$1.99M |
|
38
Liberty Media Series C
FWONK
$24.6B
| – | – |
-120,433
| Closed | -$3.69M |
|
|
39
Regeneron Pharmaceuticals
REGN
$77.6B
| – | – |
-56,053
| Closed | -$35M |
|
|
40
UnitedHealth
UNH
$381B
| – | – |
-145,627
| Closed | -$43M |
|
|
WORK
41
DELISTED
Slack Technologies, Inc.
WORK
| – | – |
-611,713
| Closed | -$19M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2020 Portfolio in Review
As of Q3 2020, Bridger Management held 41 positions worth $1.25B, up 16% from $1.08B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Bridger Management deployed $78.7M of net new capital in Q3 2020, opening 6 new positions and adding to 4 existing holdings. Its largest new stake was American Well: 231,637 shares worth $137M.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 51% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Labcorp, an estimated $44.9M trimmed.
- Bridger Management's largest Q3 2020 buy was American Well: 231,637 shares worth $137M.
- Bridger Management added most to Alcon in Q3 2020, an estimated $8.8M increase.
- Bridger Management's biggest Q3 2020 reduction was Labcorp, cutting an estimated $44.9M.
- Bridger Management fully exited UnitedHealth in Q3 2020, selling an estimated $43M.
- Bridger Management's ten largest holdings make up 55% of its $1.25B portfolio in Q3 2020.
- Bridger Management opened 6 new positions and closed 5 in Q3 2020.
- Bridger Management's portfolio value rose 16% quarter-over-quarter to $1.25B.
Based on Bridger Management's 13F filing for Q3 2020, filed 16 Nov 2020.